vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

USCB FINANCIAL HOLDINGS, INC. is the larger business by last-quarter revenue ($22.2M vs $18.8M, roughly 1.2× BIOLIFE SOLUTIONS INC). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs 6.1%, a 52.8% gap on every dollar of revenue. On growth, BIOLIFE SOLUTIONS INC posted the faster year-over-year revenue change (24.3% vs 14.7%). Over the past eight quarters, USCB FINANCIAL HOLDINGS, INC.'s revenue compounded faster (12.3% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

BLFS vs USCB — Head-to-Head

Bigger by revenue
USCB
USCB
1.2× larger
USCB
$22.2M
$18.8M
BLFS
Growing faster (revenue YoY)
BLFS
BLFS
+9.6% gap
BLFS
24.3%
14.7%
USCB
Higher net margin
BLFS
BLFS
52.8% more per $
BLFS
58.9%
6.1%
USCB
Faster 2-yr revenue CAGR
USCB
USCB
Annualised
USCB
12.3%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
USCB
USCB
Revenue
$18.8M
$22.2M
Net Profit
$11.1M
$1.4M
Gross Margin
Operating Margin
7.2%
14.7%
Net Margin
58.9%
6.1%
Revenue YoY
24.3%
14.7%
Net Profit YoY
-11.1%
-80.3%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
USCB
USCB
Q4 25
$18.8M
$22.2M
Q3 25
$28.1M
$25.0M
Q2 25
$25.4M
$24.4M
Q1 25
$23.9M
$22.8M
Q4 24
$15.1M
$23.0M
Q3 24
$21.4M
$21.5M
Q2 24
$19.7M
$20.5M
Q1 24
$18.4M
$17.6M
Net Profit
BLFS
BLFS
USCB
USCB
Q4 25
$11.1M
$1.4M
Q3 25
$621.0K
$8.9M
Q2 25
$-15.8M
$8.1M
Q1 25
$-448.0K
$7.7M
Q4 24
$12.5M
$6.9M
Q3 24
$-1.7M
$6.9M
Q2 24
$-20.7M
$6.2M
Q1 24
$-10.2M
$4.6M
Operating Margin
BLFS
BLFS
USCB
USCB
Q4 25
7.2%
14.7%
Q3 25
-0.3%
47.3%
Q2 25
-65.5%
44.0%
Q1 25
-5.1%
44.2%
Q4 24
3.6%
39.6%
Q3 24
-2.0%
42.5%
Q2 24
-6.6%
39.8%
Q1 24
-17.9%
34.3%
Net Margin
BLFS
BLFS
USCB
USCB
Q4 25
58.9%
6.1%
Q3 25
2.2%
35.8%
Q2 25
-62.3%
33.4%
Q1 25
-1.9%
33.5%
Q4 24
82.5%
30.0%
Q3 24
-8.0%
32.3%
Q2 24
-105.1%
30.3%
Q1 24
-55.4%
26.2%
EPS (diluted)
BLFS
BLFS
USCB
USCB
Q4 25
$0.23
Q3 25
$0.01
$0.45
Q2 25
$-0.33
Q1 25
$-0.01
Q4 24
$0.27
Q3 24
$-0.04
$0.35
Q2 24
$-0.45
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$33.0M
$38.5M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$371.9M
$217.2M
Total Assets
$405.9M
$2.8B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
USCB
USCB
Q4 25
$33.0M
$38.5M
Q3 25
$29.5M
$56.8M
Q2 25
$31.9M
$54.8M
Q1 25
$66.9M
$98.0M
Q4 24
$91.5M
$77.0M
Q3 24
$24.0M
$38.5M
Q2 24
$22.0M
$77.3M
Q1 24
$29.7M
$126.5M
Total Debt
BLFS
BLFS
USCB
USCB
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
BLFS
BLFS
USCB
USCB
Q4 25
$371.9M
$217.2M
Q3 25
$353.7M
$209.1M
Q2 25
$347.2M
$231.6M
Q1 25
$352.6M
$225.1M
Q4 24
$348.9M
$215.4M
Q3 24
$325.5M
$213.9M
Q2 24
$321.4M
$201.0M
Q1 24
$333.4M
$195.0M
Total Assets
BLFS
BLFS
USCB
USCB
Q4 25
$405.9M
$2.8B
Q3 25
$392.1M
$2.8B
Q2 25
$387.2M
$2.7B
Q1 25
$395.1M
$2.7B
Q4 24
$399.5M
$2.6B
Q3 24
$381.7M
$2.5B
Q2 24
$375.0M
$2.5B
Q1 24
$401.6M
$2.5B
Debt / Equity
BLFS
BLFS
USCB
USCB
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
USCB
USCB
Operating Cash FlowLast quarter
$4.9M
$42.8M
Free Cash FlowOCF − Capex
$42.5M
FCF MarginFCF / Revenue
191.4%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
0.44×
31.40×
TTM Free Cash FlowTrailing 4 quarters
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
USCB
USCB
Q4 25
$4.9M
$42.8M
Q3 25
$6.1M
$20.1M
Q2 25
$7.4M
$18.0M
Q1 25
$1.7M
$14.6M
Q4 24
$1.6M
$34.8M
Q3 24
$4.8M
$11.3M
Q2 24
$6.5M
$18.3M
Q1 24
$-4.5M
$8.1M
Free Cash Flow
BLFS
BLFS
USCB
USCB
Q4 25
$42.5M
Q3 25
$20.0M
Q2 25
$18.0M
Q1 25
$14.6M
Q4 24
$34.5M
Q3 24
$11.2M
Q2 24
$18.2M
Q1 24
$8.0M
FCF Margin
BLFS
BLFS
USCB
USCB
Q4 25
191.4%
Q3 25
80.3%
Q2 25
73.7%
Q1 25
63.9%
Q4 24
150.2%
Q3 24
52.2%
Q2 24
88.8%
Q1 24
45.4%
Capex Intensity
BLFS
BLFS
USCB
USCB
Q4 25
1.4%
Q3 25
0.5%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
1.4%
Q3 24
0.4%
Q2 24
0.4%
Q1 24
0.5%
Cash Conversion
BLFS
BLFS
USCB
USCB
Q4 25
0.44×
31.40×
Q3 25
9.83×
2.25×
Q2 25
2.22×
Q1 25
1.91×
Q4 24
0.13×
5.05×
Q3 24
1.63×
Q2 24
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons